MDCX
Valuation Ratios
| Breakdown | 2024-12-31 |
|---|---|
| Price to Earnings | -2.09 |
| Price to Sales | |
| Book Value Per Common Share | |
| Price to Book | |
| Price to Operating Cash Flow | -2.28 |
| Price to Free Cash Flow | |
| Enterprise Value to EBITDA |
| Breakdown | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Price to Earnings | -1.21 | -3.69 | -8.86 | |
| Price to Sales | ||||
| Book Value Per Common Share | -0.04 | |||
| Price to Book | -53.34 | |||
| Price to Operating Cash Flow | -2.41 | -4.40 | -11.55 | |
| Price to Free Cash Flow | ||||
| Enterprise Value to EBITDA |
Earnings Data
| Breakdown | 2024-12-31 |
|---|---|
| Earning YoY | |
| Revenue YoY | |
| EBITDA YoY | |
| Net Profit YoY |
| Breakdown | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Earning YoY | ||||
| Revenue YoY | ||||
| EBITDA YoY | ||||
| Net Profit YoY |
Financial Strength
| Breakdown | 2024-12-31 |
|---|---|
| Cash Per Common Share | 0.43 |
| Quick Ratio | |
| Current Ratio | 2.33 |
| Debt to Equity | 0.80 |
| Long-Term Debt to Equity | 0.07 |
| Breakdown | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Cash Per Common Share | 0.51 | 0.70 | 0.33 | 0.35 |
| Quick Ratio | ||||
| Current Ratio | 0.92 | 1.29 | 1.53 | 2.33 |
| Debt to Equity | -13.40 | 2.67 | 1.63 | 0.80 |
| Long-Term Debt to Equity | -0.15 | 0.04 | 0.08 | 0.07 |
Profitability
| Breakdown | 2024-12-31 |
|---|---|
| ROA | -197.55 |
| ROE | -355.87 |
| Gross Margin | |
| Operating Margin | |
| EBITDA Margin | |
| Net Profit Margin |
| Breakdown | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| ROA | -322.86 | -94.50 | -90.18 | |
| ROE | 4002.32 | -347.17 | -237.59 | |
| Gross Margin | ||||
| Operating Margin | ||||
| EBITDA Margin | ||||
| Net Profit Margin |
Dividends
| Breakdown | 2024-12-31 |
|---|---|
| Dividend Yield | |
| Dividend Payout Ratio |
| Breakdown | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Dividend Yield | ||||
| Dividend Payout Ratio |
Financial Statements
| Breakdown | 2024-12-31 |
|---|---|
| Assets | 5,646.88 |
| Current Assets | 5,378.31 |
| Cash and Short-Term Investments | 4,164.32 |
| Cash and Cash Equivalents | 4,164.32 |
| Short-Term Investments | 0 |
| Net Receivables | 0 |
| Inventory | 0 |
| Other Current Assets | 1,213.98 |
| Non-Current Assets | 268.57 |
| Property, Plant, Equipment Net | 268.57 |
| Goodwill | 0 |
| Intangible Assets | 0 |
| Long-Term Investments | 0 |
| Non-Current Deferred Assets | 0 |
| Other Non-Current Assets | 0.00 |
| Liabilities | 2,512.17 |
| Current Liabilities | 2,306.23 |
| Payables and Expenses | 762.84 |
| Account Payables | 1,284.61 |
| Current Accrued Liabilities | 495.02 |
| Short-Term Debt | 116.32 |
| Other Current Liabilities | 1,427.07 |
| Non-Current Liabilities | 205.94 |
| Long-Term Debt | 205.94 |
| Other Non-Current Liabilities | 0.00 |
| Equity | 3,134.70 |
| Shareholders Equity | 0 |
| Capital Stock | 30,518.19 |
| Share Premium | 1,520.41 |
| Retained Earnings | -28,903.90 |
| Treasury Shares | 0 |
| Accumulated Other Comprehensive Income | 0 |
| Minority Interest | 0 |
| Debt | 322.27 |
| Common Shares Outstanding | 11,816.72 |
| Breakdown | 2024-12-31 |
|---|---|
| Operating Expenses | 11,180.90 |
| Selling, General and Administrative Expenses | 7,653.12 |
| Research and Development Expenses | 3,527.79 |
| Other Operating Expenses | 0.00 |
| Operating Income | -11,180.90 |
| Interest Expense | 0.00 |
| EBT | 0 |
| Income Tax | 0.00 |
| Net Income Including Non-Controlling Interests | -22,311.03 |
| Net Income Non-Controlling Interests | 11,155.52 |
| Net Income | -11,155.52 |
| Deprecation and Amortization | 0.00 |
| EPS | -0.00 |
| Diluted EPS | -0.00 |
| Average Shares Outstanding Basic | 9,619.18 |
| Average Shares Outstanding Diluted | 9,619.18 |
| Breakdown | 2024-12-31 |
|---|---|
| Operating Cash Flow | -10,247.23 |
| Operating Net Income | -11,155.52 |
| Deprecation and Amortization | 0 |
| Deferred Income Tax | 0 |
| Share Based Compensation | 713.12 |
| Change in Working Capital | 2,113.46 |
| Other Operating Activities | -1,918.29 |
| Investing Cash Flow | 0 |
| Capital Expenditure | 0.00 |
| Net Purchase/Sale of PPE | 0 |
| Net Purchase/Sale of Investments Net | 0 |
| Net Purchase/Sale of Business | 0 |
| Other Investing Activities | 0 |
| Financing Cash Flow | 12,692.22 |
| Net Issuance/Repayment of Debt | 5,172.50 |
| Net Issuance/Repurchase of Equity | 7,519.72 |
| Dividends Paid | 0 |
| Other Financing Activities | 0.00 |
| Net Change in Cash | 2,444.99 |
| Cash at Beginning of Period | 1,719.34 |
| Cash at End of Period | 4,164.32 |
| Free Cash Flow | 0 |
| Breakdown | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Assets | 9,977.66 | 11,934.63 | 5,657.87 | 5,646.88 |
| Current Assets | 9,781.41 | 10,996.73 | 5,087.77 | 5,378.31 |
| Cash and Short-Term Investments | 8,662.09 | 9,669.55 | 3,982.43 | 4,164.32 |
| Cash and Cash Equivalents | 8,662.09 | 9,669.55 | 3,982.43 | 4,164.32 |
| Short-Term Investments | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 |
| Other Current Assets | 1,119.32 | 1,327.18 | 1,105.35 | 1,213.98 |
| Non-Current Assets | 196.25 | 937.90 | 570.09 | 268.57 |
| Property, Plant, Equipment Net | 196.25 | 221.00 | 245.09 | 268.57 |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 |
| Non-Current Deferred Assets | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0.00 | 716.90 | 325.00 | 0.00 |
| Liabilities | 10,782.55 | 8,685.92 | 3,510.31 | 2,512.17 |
| Current Liabilities | 10,657.90 | 8,544.17 | 3,335.91 | 2,306.23 |
| Payables and Expenses | 1,560.43 | 1,828.31 | 1,062.04 | 762.84 |
| Account Payables | 2,027.51 | 1,770.18 | 2,035.36 | 1,284.61 |
| Current Accrued Liabilities | 645.33 | 1,040.62 | 553.84 | 495.02 |
| Short-Term Debt | 13,712.69 | 14,224.40 | 120.30 | 116.32 |
| Other Current Liabilities | -4,615.22 | -7,508.55 | 2,153.58 | 1,427.07 |
| Non-Current Liabilities | 124.65 | 141.75 | 174.40 | 205.94 |
| Long-Term Debt | 124.65 | 141.75 | 174.40 | 205.94 |
| Other Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | -804.89 | 3,248.71 | 2,147.55 | 3,134.70 |
| Shareholders Equity | -910.13 | 0 | 0 | 0 |
| Capital Stock | 0.00 | 37,834.00 | 32,908.70 | 30,518.19 |
| Share Premium | 6,449.86 | 5,597.11 | 3,245.16 | 1,520.41 |
| Retained Earnings | -0.01 | -67,980.55 | -34,006.31 | -28,903.90 |
| Treasury Shares | 0 | 0 | 0 | 0 |
| Accumulated Other Comprehensive Income | 10.68 | 0 | 0 | 0 |
| Minority Interest | 105.24 | 0 | 0 | 0 |
| Debt | 13,837.34 | 14,366.16 | 294.69 | 322.27 |
| Net Debt | 5,175.25 | 4,696.61 | 0 | 0 |
| Common Shares Outstanding | 20,971.12 | 15,936.27 | 13,417.56 | 11,816.72 |
| Breakdown | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|
| Operating Expenses | 26,568.70 | 11,142.36 | 5,126.27 |
| Selling, General and Administrative Expenses | 12,720.67 | 7,696.58 | 3,120.06 |
| Research and Development Expenses | 13,848.04 | 3,445.78 | 2,006.21 |
| Other Operating Expenses | 0.00 | 0.00 | 0.00 |
| Operating Income | -26,568.70 | -11,142.36 | -5,126.27 |
| Interest Expense | 0.00 | 0.00 | 0.00 |
| Net Interest | 75.44 | 63.87 | 0 |
| EBT | 0 | 0 | 0 |
| Income Tax | 0.00 | 0.00 | 0.00 |
| Net Income Including Non-Controlling Interests | -32,214.17 | -11,278.49 | -10,204.82 |
| Net Income Non-Controlling Interests | -0.08 | 0.00 | 5,102.41 |
| Net Income | -32,214.24 | -11,278.49 | -5,102.41 |
| Deprecation and Amortization | 0.00 | 0.00 | 0.00 |
| EPS | -0.00 | -0.00 | -0.00 |
| Diluted EPS | -0.00 | -0.00 | -0.00 |
| Average Shares Outstanding Basic | 16,844.61 | 13,853.31 | 12,240.44 |
| Average Shares Outstanding Diluted | 16,844.61 | 13,853.31 | 12,240.44 |
| Breakdown | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|
| Operating Cash Flow | -16,167.65 | -9,409.83 | -3,940.99 |
| Operating Net Income | -27,259.80 | -11,278.49 | -5,102.41 |
| Deprecation and Amortization | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 |
| Share Based Compensation | 1,082.48 | 229.72 | 112.28 |
| Change in Working Capital | -691.94 | 1,506.05 | 780.38 |
| Other Operating Activities | 10,701.61 | 132.90 | 268.76 |
| Investing Cash Flow | -4,619.15 | 0 | 0 |
| Capital Expenditure | 0.00 | 0.00 | 0.00 |
| Net Purchase/Sale of PPE | 0 | 0 | 0 |
| Net Purchase/Sale of Investments Net | 0 | 0 | 0 |
| Net Purchase/Sale of Business | 0 | 0 | 0 |
| Other Investing Activities | -4,619.15 | 0 | 0 |
| Financing Cash Flow | 25,286.31 | 14,915.05 | 3,759.10 |
| Net Issuance/Repayment of Debt | 17,504.00 | 4,500.00 | 0 |
| Net Issuance/Repurchase of Equity | 24,508.22 | 1,580.16 | 0 |
| Dividends Paid | 0 | 0 | 0 |
| Other Financing Activities | -16,725.90 | 8,834.89 | 3,759.10 |
| Net Change in Cash | 4,497.77 | 5,505.22 | -181.89 |
| Cash at Beginning of Period | 4,164.32 | 4,164.32 | 4,164.32 |
| Cash at End of Period | 8,662.09 | 9,669.55 | 3,982.43 |
| Free Cash Flow | 0 | 0 | 0 |